Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	coumarin 7-hydroxylase activity	CYP2A6 CYP2A7 CYP2A13	1.63e-07	3	110	3	GO:0008389
GeneOntologyMolecularFunction	arachidonate epoxygenase activity	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	1.81e-07	24	110	5	GO:0008392
GeneOntologyMolecularFunction	arachidonate monooxygenase activity	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	3.39e-07	27	110	5	GO:0008391
GeneOntologyMolecularFunction	aromatase activity	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	1.32e-06	35	110	5	GO:0070330
GeneOntologyMolecularFunction	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	7.28e-06	49	110	5	GO:0016712
GeneOntologyMolecularFunction	steroid hydroxylase activity	CYP2A6 CYP2A7 CYP2A13 CYP2B6	3.56e-05	34	110	4	GO:0008395
GeneOntologyMolecularFunction	monooxygenase activity	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	4.39e-04	115	110	5	GO:0004497
GeneOntologyBiologicalProcess	epoxygenase P450 pathway	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	9.21e-08	22	109	5	GO:0019373
GeneOntologyBiologicalProcess	long-chain fatty acid metabolic process	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11 ACSL4 ACSBG1 ABCD1	3.11e-07	124	109	8	GO:0001676
GeneOntologyBiologicalProcess	phenylpropanoid metabolic process	CYP2A6 CYP2A7 CYP2A13	1.68e-05	10	109	3	GO:0009698
GeneOntologyBiologicalProcess	coumarin metabolic process	CYP2A6 CYP2A7 CYP2A13	1.68e-05	10	109	3	GO:0009804
GeneOntologyBiologicalProcess	olfactory nerve formation	PLXNA3 PLXNA1	2.77e-05	2	109	2	GO:0021628
GeneOntologyBiologicalProcess	arachidonate metabolic process	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	3.01e-05	68	109	5	GO:0019369
GeneOntologyBiologicalProcess	intracellular distribution of mitochondria	OGT LRRK2 CLUH	3.05e-05	12	109	3	GO:0048312
GeneOntologyBiologicalProcess	olefinic compound metabolic process	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CEL CYP4A11 ABCD1	4.83e-05	180	109	7	GO:0120254
GeneOntologyBiologicalProcess	unsaturated fatty acid metabolic process	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11 ABCD1	6.10e-05	128	109	6	GO:0033559
GeneOntologyBiologicalProcess	fatty-acyl-CoA metabolic process	ACSL4 ACSBG1 ABCD1 FAR1	7.08e-05	42	109	4	GO:0035337
GeneOntologyBiologicalProcess	fatty acid derivative metabolic process	CYP4A11 ACSL4 ACSBG1 ABCD1 FAR1	7.42e-05	82	109	5	GO:1901568
GeneOntologyBiologicalProcess	olfactory nerve morphogenesis	PLXNA3 PLXNA1	8.27e-05	3	109	2	GO:0021627
GeneOntologyBiologicalProcess	ganglioside biosynthetic process	ST6GALNAC1 ST3GAL3 B4GALT6	1.11e-04	18	109	3	GO:0001574
GeneOntologyBiologicalProcess	fatty acid metabolic process	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11 ACSL4 PER2 ACSBG1 SLC22A13 ABCD1	1.67e-04	461	109	10	GO:0006631
Domain	Cyt_P450_E_grp-I_CYP2A-like	CYP2A6 CYP2A7 CYP2A13	7.92e-07	4	110	3	IPR008067
Domain	Cyt_P450_E_grp-I	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	6.55e-06	45	110	5	IPR002401
Domain	Cyt_P450_CS	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	1.48e-05	53	110	5	IPR017972
Domain	CYTOCHROME_P450	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	2.12e-05	57	110	5	PS00086
Domain	-	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	2.31e-05	58	110	5	1.10.630.10
Domain	p450	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	2.31e-05	58	110	5	PF00067
Domain	Cyt_P450	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	2.73e-05	60	110	5	IPR001128
Domain	TPR-like_helical_dom	OGT NAA15 WFS1 SNX20 COPB2 TMTC3 CLUH CRTAP	7.14e-05	233	110	8	IPR011990
Domain	-	OGT NAA15 WFS1 SNX20 TMTC3 CLUH CRTAP	2.25e-04	207	110	7	1.25.40.10
Domain	ABC_TM1F	ABCC3 ABCB5 ABCD1	5.85e-04	28	110	3	PS50929
Domain	ABC1_TM_dom	ABCC3 ABCB5 ABCD1	5.85e-04	28	110	3	IPR011527
Domain	SWIM	ZSWIM5 ZSWIM4	7.08e-04	7	110	2	PF04434
Domain	Plexin_cytopl	PLXNA3 PLXNA1	1.20e-03	9	110	2	PF08337
Domain	Plexin_cytoplasmic_RasGAP_dom	PLXNA3 PLXNA1	1.20e-03	9	110	2	IPR013548
Domain	Plexin	PLXNA3 PLXNA1	1.20e-03	9	110	2	IPR031148
Domain	Znf_SWIM	ZSWIM5 ZSWIM4	1.20e-03	9	110	2	IPR007527
Domain	ZF_SWIM	ZSWIM5 ZSWIM4	1.20e-03	9	110	2	PS50966
Domain	PH	NIBAN2 MPRIP BTK PLCL2 PRKD1 PLCG1 SOS2	1.30e-03	278	110	7	SM00233
Domain	PH_DOMAIN	NIBAN2 MPRIP BTK PLCL2 PRKD1 PLCG1 SOS2	1.32e-03	279	110	7	PS50003
Domain	PH_domain	NIBAN2 MPRIP BTK PLCL2 PRKD1 PLCG1 SOS2	1.35e-03	280	110	7	IPR001849
Domain	ABC_transporter_CS	ABCC3 ABCB5 ABCD1	1.93e-03	42	110	3	IPR017871
Domain	OTU	OTUD6B OTUD4	2.57e-03	13	110	2	PF02338
Domain	ABC_tran	ABCC3 ABCB5 ABCD1	2.84e-03	48	110	3	PF00005
Domain	ABC_TRANSPORTER_2	ABCC3 ABCB5 ABCD1	2.84e-03	48	110	3	PS50893
Domain	ABC_TRANSPORTER_1	ABCC3 ABCB5 ABCD1	3.01e-03	49	110	3	PS00211
Domain	ABC_transporter-like	ABCC3 ABCB5 ABCD1	3.19e-03	50	110	3	IPR003439
Domain	OTU	OTUD6B OTUD4	3.43e-03	15	110	2	PS50802
Domain	PLipase_C_Pinositol-sp_Y	PLCL2 PLCG1	3.43e-03	15	110	2	IPR001711
Domain	EF-hand_like	PLCL2 PLCG1	3.43e-03	15	110	2	PF09279
Domain	PIPLC_Y_DOMAIN	PLCL2 PLCG1	3.43e-03	15	110	2	PS50008
Domain	PI-PLC_fam	PLCL2 PLCG1	3.43e-03	15	110	2	IPR001192
Domain	PLC_EF-hand-like	PLCL2 PLCG1	3.43e-03	15	110	2	IPR015359
Domain	PI-PLC-Y	PLCL2 PLCG1	3.43e-03	15	110	2	PF00387
Domain	PLCYc	PLCL2 PLCG1	3.43e-03	15	110	2	SM00149
Domain	OTU_dom	OTUD6B OTUD4	3.43e-03	15	110	2	IPR003323
Domain	TPR_8	OGT NAA15 TMTC3	3.76e-03	53	110	3	PF13181
Domain	Actin_CS	POTEF ACTG2	3.91e-03	16	110	2	IPR004001
Domain	ACTINS_2	POTEF ACTG2	4.41e-03	17	110	2	PS00432
Domain	Pept_M10A_stromelysin-type	MMP28 MMP17	4.95e-03	18	110	2	IPR016293
Domain	PI-PLC-X	PLCL2 PLCG1	4.95e-03	18	110	2	PF00388
Domain	Actin/actin-like_CS	POTEF ACTG2	4.95e-03	18	110	2	IPR020902
Domain	PLCXc	PLCL2 PLCG1	4.95e-03	18	110	2	SM00148
Domain	PIPLC_X_DOMAIN	PLCL2 PLCG1	5.51e-03	19	110	2	PS50007
Domain	PLipase_C_PInositol-sp_X_dom	PLCL2 PLCG1	5.51e-03	19	110	2	IPR000909
Domain	ACTINS_ACT_LIKE	POTEF ACTG2	5.51e-03	19	110	2	PS01132
Pathway	REACTOME_FATTY_ACIDS	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	6.79e-08	18	88	5	MM14841
Pathway	REACTOME_CYP2E1_REACTIONS	CYP2A6 CYP2A7 CYP2A13 CYP2B6	4.52e-07	11	88	4	M27130
Pathway	REACTOME_CYP2E1_REACTIONS	CYP2A6 CYP2A7 CYP2A13 CYP2B6	6.75e-07	12	88	4	MM14847
Pathway	REACTOME_FATTY_ACIDS	CYP2A7 CYP2A13 CYP2B6 CYP4A11	1.84e-06	15	88	4	M27126
Pathway	REACTOME_XENOBIOTICS	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.15e-05	23	88	4	M5372
Pathway	REACTOME_XENOBIOTICS	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.62e-05	25	88	4	MM14846
Pathway	WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY	ABCC3 CYP2A6 CYP2B6 CYP4A11	3.92e-05	31	88	4	M39476
Pathway	WP_OXIDATION_BY_CYTOCHROME_P450	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	4.13e-05	62	88	5	M39653
Pathway	REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	4.82e-05	64	88	5	M5650
Pathway	KEGG_RETINOL_METABOLISM	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	4.82e-05	64	88	5	M9488
Pathway	WP_VALPROIC_ACID_PATHWAY	CYP2A6 CYP2B6 HDAC1	4.97e-05	12	88	3	M39371
Pathway	REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	5.60e-05	66	88	5	MM14839
Pathway	KEGG_MEDICUS_ENV_FACTOR_NNK_TO_DNA_ADDUCTS	CYP2A6 CYP2A13	3.81e-04	5	88	2	M47808
Pathway	REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	4.78e-04	104	88	5	M738
Pathway	REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	5.00e-04	105	88	5	MM14842
Pathway	WP_NICOTINE_METABOLISM_IN_LIVER_CELLS	CYP2A6 CYP2B6	5.69e-04	6	88	2	M39600
Pubmed	Two steroid 15 alpha-hydroxylase genes and a homologous gene family in mice.	CYP2A6 CYP2A7 CYP2A13 CYP2B6	9.83e-11	4	111	4	1970547
Pubmed	Establishment and analysis of a mouse model that regulates sex-related differences in liver drug metabolism.	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	8.85e-10	15	111	5	29968852
Pubmed	A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles.	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.47e-09	6	111	4	7668294
Pubmed	Organization and evolution of the cytochrome P450 CYP2A-2B-2F subfamily gene cluster on human chromosome 19.	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.47e-09	6	111	4	8587134
Pubmed	Zinc Fingers and Homeoboxes 2 (Zhx2) Regulates Sexually Dimorphic Cyp Gene Expression in the Adult Mouse Liver.	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	1.81e-09	17	111	5	27197076
Pubmed	Catalog of 680 variations among eight cytochrome p450 ( CYP) genes, nine esterase genes, and two other genes in the Japanese population.	CYP2A6 CYP2A13 CYP2B6 CEL TGM1	3.39e-09	19	111	5	12721789
Pubmed	Organization and evolution of the Cyp2 gene cluster on mouse chromosome 7, and comparison with the syntenic human cluster.	CYP2A6 CYP2A7 CYP2A13 CYP2B6	3.41e-09	7	111	4	14630516
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	KNTC1 MYO1C DDX60 ZNFX1 PRPF8 MPRIP NBAS TMTC3 HECTD1	1.91e-08	202	111	9	33005030
Pubmed	Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition.	CYP2A6 CYP2A7 CYP2A13	3.16e-08	3	111	3	31645370
Pubmed	Rip locus: regulation of female-specific isozyme (I-P-450(16 alpha) of testosterone 16 alpha-hydroxylase in mouse liver, chromosome localization, and cloning of P-450 cDNA.	CYP2A6 CYP2A13 CYP2B6	3.16e-08	3	111	3	3219345
Pubmed	A trans-acting locus regulates transcriptional repression of the female-specific steroid 15 alpha-hydroxylase gene in male mice.	CYP2A6 CYP2A7 CYP2A13	3.16e-08	3	111	3	8297477
Pubmed	Lack of the steroid 15 alpha-hydroxylase gene (Cyp2a-4) in wild mouse strain Mus spretus: rapid evolution of the P450 gene superfamily.	CYP2A6 CYP2A7 CYP2A13	3.16e-08	3	111	3	8188299
Pubmed	Comparison of hamster and mouse reveals interspecies differences in the regulation of hepatic CYP2A isozymes.	CYP2A6 CYP2A7 CYP2A13	3.16e-08	3	111	3	8250953
Pubmed	The structure and characterization of type I P-450(15) alpha gene as major steroid 15 alpha-hydroxylase and its comparison with type II P-450(15) alpha gene.	CYP2A6 CYP2A7 CYP2A13	3.16e-08	3	111	3	2703500
Pubmed	Close linkage of the cytochrome P450IIA gene subfamily (Cyp2a) to Cyp2b and Coh on mouse chromosome 7.	CYP2A6 CYP2A13 CYP2B6	3.16e-08	3	111	3	1973143
Pubmed	Alteration of the substrate specificity of mouse 2A P450s by the identity of residue-209: steroid-binding site and orientation.	CYP2A6 CYP2A7 CYP2A13	3.16e-08	3	111	3	22217847
Pubmed	Differential distribution of CYP2A6 and CYP2A13 in the human respiratory tract.	CYP2A6 CYP2A7 CYP2A13	3.16e-08	3	111	3	22890016
Pubmed	Reciprocal regulation of sex-dependent expression of testosterone 15 alpha-hydroxylase (P-450(15 alpha)) in liver and kidney of male mice by androgen. Evidence for a single gene.	CYP2A6 CYP2A7 CYP2A13	3.16e-08	3	111	3	3346244
Pubmed	Alteration of mouse cytochrome P450coh substrate specificity by mutation of a single amino-acid residue.	CYP2A6 CYP2A7 CYP2A13	3.16e-08	3	111	3	2733794
Pubmed	Site-directed mutagenesis of mouse steroid 7 alpha-hydroxylase (cytochrome P-450(7) alpha): role of residue-209 in determining steroid-cytochrome P-450 interaction.	CYP2A6 CYP2A7 CYP2A13	3.16e-08	3	111	3	8484736
Pubmed	Cerium-induced strain-dependent increase in Cyp2a-4/5 (cytochrome P4502a-4/5) expression in the liver and kidneys of inbred mice.	CYP2A6 CYP2A7 CYP2A13	3.16e-08	3	111	3	1417950
Pubmed	Impact of nicotine metabolism on nicotine's pharmacological effects and behavioral responses: insights from a Cyp2a(4/5)bgs-null mouse.	CYP2A6 CYP2A7 CYP2A13	3.16e-08	3	111	3	24045421
Pubmed	Highly homologous mouse Cyp2a4 and Cyp2a5 genes are differentially expressed in the liver and both express long non-coding antisense RNAs.	CYP2A6 CYP2A7 CYP2A13	3.16e-08	3	111	3	32987105
Pubmed	Mouse steroid 15 alpha-hydroxylase gene family: identification of type II P-450(15)alpha as coumarin 7-hydroxylase.	CYP2A6 CYP2A7 CYP2A13	3.16e-08	3	111	3	2765478
Pubmed	Sexual dimorphism of testosterone 15 alpha-hydroxylase mRNA levels in mouse liver. cDNA cloning and regulation.	CYP2A6 CYP2A7 CYP2A13	3.16e-08	3	111	3	2415518
Pubmed	Circadian expression of the steroid 15 alpha-hydroxylase (Cyp2a4) and coumarin 7-hydroxylase (Cyp2a5) genes in mouse liver is regulated by the PAR leucine zipper transcription factor DBP.	CYP2A6 CYP2A7 CYP2A13	1.26e-07	4	111	3	10490589
Pubmed	Possible involvement of nuclear factor erythroid 2-related factor 2 in the gene expression of Cyp2b10 and Cyp2a5.	CYP2A6 CYP2A13 CYP2B6	1.26e-07	4	111	3	24494203
Pubmed	Transcriptional regulation by HNF-4 of the steroid 15alpha-hydroxylase P450 (Cyp2a-4) gene in mouse liver.	CYP2A6 CYP2A7 CYP2A13	1.26e-07	4	111	3	9408084
Pubmed	A DNA methylation site in the male-specific P450 (Cyp 2d-9) promoter and binding of the heteromeric transcription factor GABP.	CYP2A6 CYP2A7 CYP2A13	1.26e-07	4	111	3	7565685
Pubmed	Interactome and Ubiquitinome Analyses Identify Functional Targets of Herpes Simplex Virus 1 Infected Cell Protein 0.	MYO1C COPB2 FAM91A1 PRPF8 MPRIP WDR11 OTUD4	1.54e-07	124	111	7	35516420
Pubmed	Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues.	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	2.97e-07	44	111	5	12745259
Pubmed	Molecular genetics of the human cytochrome P450 monooxygenase superfamily.	CYP2A6 CYP2A7 CYP2A13 CYP2B6	4.58e-07	20	111	4	9890157
Pubmed	Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses.	CYP2A6 CYP2A7 CYP2A13	1.10e-06	7	111	3	9630227
Pubmed	Resveratrol improves health and survival of mice on a high-calorie diet.	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.39e-06	26	111	4	17086191
Pubmed	Maternal DHA intake in mice increased DHA metabolites in the pup brain and ameliorated MeHg-induced behavioral disorder.	CYP2A6 CYP2A7 CYP2A13	2.62e-06	9	111	3	37838304
Pubmed	Association study between single-nucleotide polymorphisms in 199 drug-related genes and commonly measured quantitative traits of 752 healthy Japanese subjects.	ABCC3 CYP2A6 CYP2A13 CYP2B6 CYP4A11 TGM1 ABCD1	3.03e-06	193	111	7	19343046
Pubmed	Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants.	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	3.10e-06	70	111	5	15128046
Pubmed	SoxC Transcription Factors Promote Contralateral Retinal Ganglion Cell Differentiation and Axon Guidance in the Mouse Visual System.	SOX4 SOX11 PLXNA1	3.74e-06	10	111	3	28215559
Pubmed	Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity.	CYP2A6 CYP2A7	1.01e-05	2	111	2	12325023
Pubmed	Suppressed hepatocyte proliferation via a ROS-HNE-P21 pathway is associated with nicotine- and cotinine-enhanced alcoholic fatty liver in mice.	CYP2A6 CYP2A13	1.01e-05	2	111	2	30876690
Pubmed	Differential expression of SOX4 and SOX11 in medulloblastoma.	SOX4 SOX11	1.01e-05	2	111	2	12125983
Pubmed	CYP2A5 induction and hepatocellular stress: an adaptive response to perturbations of heme homeostasis.	CYP2A6 CYP2A13	1.01e-05	2	111	2	21395539
Pubmed	Species differences in coumarin metabolism: a molecular modelling evaluation of CYP2A interactions.	CYP2A6 CYP2A13	1.01e-05	2	111	2	12162851
Pubmed	Molecular characterization of the murine Coh locus: an amino acid difference at position 117 confers high and low coumarin 7-hydroxylase activity in P450coh.	CYP2A6 CYP2A13	1.01e-05	2	111	2	1302041
Pubmed	Structural alteration of mouse P450coh by mutation of glycine-207 to proline: spin equilibrium, enzyme kinetics, and heat sensitivity.	CYP2A6 CYP2A13	1.01e-05	2	111	2	8395817
Pubmed	Absence of cytochrome P450 2A5 enhances alcohol-induced liver injury in mice.	CYP2A6 CYP2A13	1.01e-05	2	111	2	25804444
Pubmed	SoxC transcription factors are required for neuronal differentiation in adult hippocampal neurogenesis.	SOX4 SOX11	1.01e-05	2	111	2	22378879
Pubmed	Effect of pyrazole, cobalt and phenobarbital on mouse liver cytochrome P-450 2a-4/5 (Cyp2a-4/5) expression.	CYP2A6 CYP2A13	1.01e-05	2	111	2	1520280
Pubmed	Gene-gene interactions between CYP2B6 and CYP2A6 in nicotine metabolism.	CYP2A6 CYP2B6	1.01e-05	2	111	2	18004205
Pubmed	Role of CYP2A13 in the bioactivation and lung tumorigenicity of the tobacco-specific lung procarcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: in vivo studies using a CYP2A13-humanized mouse model.	CYP2A6 CYP2A13	1.01e-05	2	111	2	23917075
Pubmed	CYP2A7 polymorphic alleles confound the genotyping of CYP2A6*4A allele.	CYP2A6 CYP2A7	1.01e-05	2	111	2	16636685
Pubmed	Genomic Landscape of Experimental Bladder Cancer in Rodents and Its Application to Human Bladder Cancer: Gene Amplification and Potential Overexpression of Cyp2a5/CYP2A6 Are Associated with the Invasive Phenotype.	CYP2A6 CYP2A13	1.01e-05	2	111	2	27902773
Pubmed	Bruton's tyrosine kinase (Btk) associates with protein kinase C mu.	BTK PRKD1	1.01e-05	2	111	2	10561498
Pubmed	Genetic variants in CYP2B6 and CYP2A6 explain interindividual variation in efavirenz plasma concentrations of HIV-infected children with diverse ethnic origin.	CYP2A6 CYP2B6	1.01e-05	2	111	2	28886044
Pubmed	Murine bubblegum orthologue is a microsomal very long-chain acyl-CoA synthetase.	ACSBG1 ABCD1	1.01e-05	2	111	2	14516277
Pubmed	Circadian Regulation of Hepatic Cytochrome P450 2a5 by Peroxisome Proliferator-Activated Receptor γ.	CYP2A6 CYP2A13	1.01e-05	2	111	2	30154104
Pubmed	Expression of CYP2A genes in human liver and extrahepatic tissues.	CYP2A7 CYP2A13	1.01e-05	2	111	2	10353262
Pubmed	CYP2B6 (c.516G-->T) and CYP2A6 (9B and/or 17) polymorphisms are independent predictors of efavirenz plasma concentrations in HIV-infected patients.	CYP2A6 CYP2B6	1.01e-05	2	111	2	19371316
Pubmed	Mechanism-based inhibition of cytochrome P450 (CYP)2A6 by chalepensin in recombinant systems, in human liver microsomes and in mice in vivo.	CYP2A6 CYP2A13	1.01e-05	2	111	2	21418183
Pubmed	Role of CYP2A5 in the clearance of nicotine and cotinine: insights from studies on a Cyp2a5-null mouse model.	CYP2A6 CYP2A13	1.01e-05	2	111	2	19923441
Pubmed	Effects of lipopolysaccharide-stimulated inflammation and pyrazole-mediated hepatocellular injury on mouse hepatic Cyp2a5 expression.	CYP2A6 CYP2A13	1.01e-05	2	111	2	12499123
Pubmed	Function and regulation of the Cyp2a5/CYP2A6 genes in response to toxic insults in the liver.	CYP2A6 CYP2A13	1.01e-05	2	111	2	22497566
Pubmed	The role of CYP2A5 in liver injury and fibrosis: chemical-specific difference.	CYP2A6 CYP2A13	1.01e-05	2	111	2	26363552
Pubmed	Mouse liver P450Coh: genetic regulation of the pyrazole-inducible enzyme and comparison with other P450 isoenzymes.	CYP2A6 CYP2A13	1.01e-05	2	111	2	2712571
Pubmed	Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials Participants.	CYP2A6 CYP2B6	1.01e-05	2	111	2	28931220
Pubmed	Evaluation of inhibition selectivity for human cytochrome P450 2A enzymes.	CYP2A6 CYP2A13	1.01e-05	2	111	2	22696418
Pubmed	Proliferating cell nuclear antigen associates with histone deacetylase activity, integrating DNA replication and chromatin modification.	PCNA HDAC1	1.01e-05	2	111	2	11929879
Pubmed	O-GlcNAcylation of histone deacetylases 1 in hepatocellular carcinoma promotes cancer progression.	OGT HDAC1	1.01e-05	2	111	2	27060025
Pubmed	Nicotine enhances alcoholic fatty liver in mice: Role of CYP2A5.	CYP2A6 CYP2A13	1.01e-05	2	111	2	30222954
Pubmed	Up-regulation of CYP2A5 expression by porphyrinogenic agents in mouse liver.	CYP2A6 CYP2A13	1.01e-05	2	111	2	7543189
Pubmed	Characterization and regulation of sex-specific mouse steroid hydroxylase genes.	CYP2A6 CYP2A13	1.01e-05	2	111	2	2372744
Pubmed	Human MI-ER1 alpha and beta function as transcriptional repressors by recruitment of histone deacetylase 1 to their conserved ELM2 domain.	MIER1 HDAC1	1.01e-05	2	111	2	12482978
Pubmed	The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes.	CYP2A6 CYP2A7	1.01e-05	2	111	2	2322567
Pubmed	Metabolic effects of CYP2A6 and CYP2A13 on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced gene mutation--a mammalian cell-based mutagenesis approach.	CYP2A6 CYP2A13	1.01e-05	2	111	2	21473878
Pubmed	The CYP2A gene subfamily: species differences, regulation, catalytic activities and role in chemical carcinogenesis.	CYP2A6 CYP2A13	1.01e-05	2	111	2	7581481
Pubmed	Expression and alternative splicing of the cytochrome P-450 CYP2A7.	CYP2A6 CYP2A7	1.01e-05	2	111	2	7864805
Pubmed	Interstrain differences in the expression and activity of Cyp2a5 in the mouse liver.	CYP2A6 CYP2A13	1.01e-05	2	111	2	28298240
Pubmed	Genetic polymorphisms for a phenobarbital-inducible cytochrome P-450 map to the Coh locus in mice.	CYP2A6 CYP2A13	1.01e-05	2	111	2	6309775
Pubmed	Identification of the binding site for Gqalpha on its effector Bruton's tyrosine kinase.	BTK GNAQ	1.01e-05	2	111	2	9770463
Pubmed	Role of CYP2A5 in the bioactivation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mice.	CYP2A6 CYP2A13	1.01e-05	2	111	2	22262919
Pubmed	Modulation of cytochrome P450 2A5 activity by lipopolysaccharide: low-dose effects and non-monotonic dose-response relationship.	CYP2A6 CYP2A13	1.01e-05	2	111	2	25635819
Pubmed	Genetic variation between mice in their metabolism of coumarin and its derivatives.	CYP2A6 CYP2A13	1.01e-05	2	111	2	566237
Pubmed	Identification and characterization of a 44 kDa protein that binds specifically to the 3'-untranslated region of CYP2a5 mRNA: inducibility, subcellular distribution and possible role in mRNA stabilization.	CYP2A6 CYP2A13	1.01e-05	2	111	2	8611142
Pubmed	Human Neuropeptide S Receptor Is Activated via a Gαq Protein-biased Signaling Cascade by a Human Neuropeptide S Analog Lacking the C-terminal 10 Residues.	NPSR1 GNAQ	1.01e-05	2	111	2	26865629
Pubmed	Coumarin toxicity in different strains of mice.	CYP2A6 CYP2A13	1.01e-05	2	111	2	665441
Pubmed	Determinants of the rate of nicotine metabolism and effects on smoking behavior.	CYP2A6 CYP2B6	1.01e-05	2	111	2	17015050
Pubmed	Essential role of the cytochrome P450 enzyme CYP2A5 in olfactory mucosal toxicity of naphthalene.	CYP2A6 CYP2A13	1.01e-05	2	111	2	24104196
Pubmed	The early retinal progenitor-expressed gene Sox11 regulates the timing of the differentiation of retinal cells.	SOX4 SOX11	1.01e-05	2	111	2	23318640
Pubmed	A QUICK screen for Lrrk2 interaction partners--leucine-rich repeat kinase 2 is involved in actin cytoskeleton dynamics.	MYO1C LRRK2 ACTG2 MPRIP	1.10e-05	43	111	4	20876399
Pubmed	Novel DNA sequence variations of cytochrome P450 genes in the Han Chinese population.	CYP2A6 CYP2A13 CYP2B6	1.12e-05	14	111	3	19290787
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SOX4 PLXNA3 ABCC3 KMT5C MTG2 MPRIP LATS2 PER2 PLCG1 ABCD1 MMP17 HECTD1 MED12 PLXNA1	1.18e-05	1105	111	14	35748872
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	ABCC3 NIBAN2 MIER1 CCNY TGM1 LATS2 PTPRJ GNAQ VPS51 PLXNA1	1.49e-05	569	111	10	30639242
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	KNTC1 OGT NAA15 NCKAP1 POLR2B COPB2 NIBAN2 DPP9 OTUD6B PLCG1 HECTD1 CLUH ELP4 PCNA HDAC1 CRTAP	1.56e-05	1455	111	16	22863883
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	PLXNA3 RHOJ POLR2B ACSL4 TGM1 CKS2 LATS2 DPP9 MMP17 PLXNA1 HDAC1	2.28e-05	730	111	11	34857952
Pubmed	Mitotic WNT signalling orchestrates neurogenesis in the developing neocortex.	SOX4 SOX11 CCNY	2.95e-05	19	111	3	34431536
Pubmed	Histone deacetylase 1 regulates the malignancy of oral cancer cells via miR-154-5p/PCNA axis.	PCNA HDAC1	3.02e-05	3	111	2	32549181
Pubmed	Expression of cytochrome P450 2A5 in a glucose-6-phosphate dehydrogenase-deficient mouse model of oxidative stress.	CYP2A6 CYP2A13	3.02e-05	3	111	2	18068688
Pubmed	CYP2A6/2A7 and CYP2E1 expression in human oesophageal mucosa: regional and inter-individual variation in expression and relevance to nitrosamine metabolism.	CYP2A6 CYP2A7	3.02e-05	3	111	2	11960914
Pubmed	SOX4, SOX11 and PAX6 mRNA expression was identified as a (prognostic) marker for the aggressiveness of neuroendocrine tumors of the lung by using next-generation expression analysis (NanoString).	SOX4 SOX11	3.02e-05	3	111	2	25804118
Pubmed	Zfp30, a KRAB domain containing zinc finger protein gene, maps to mouse chromosome 7.	CYP2A6 CYP2A13	3.02e-05	3	111	2	7849402
Interaction	CYP2A7 interactions	CYP2A6 CYP2A7 CYP2A13	1.46e-07	3	107	3	int:CYP2A7
Interaction	LRRC31 interactions	KNTC1 MYO1C DDX60 ZNFX1 PRPF8 MPRIP NBAS TMTC3 HECTD1	1.48e-06	205	107	9	int:LRRC31
GeneFamily	Cytochrome P450 family 2	CYP2A6 CYP2A7 CYP2A13 CYP2B6	2.03e-05	35	84	4	1001
GeneFamily	Zinc fingers SWIM-type\|Mitogen-activated protein kinase kinase kinases	ZSWIM5 ZSWIM4	7.52e-04	9	84	2	90
GeneFamily	Plexins	PLXNA3 PLXNA1	7.52e-04	9	84	2	683
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	MPRIP BTK PRKD1 PLCG1 SOS2	2.73e-03	206	84	5	682
GeneFamily	OTU domain containing	OTUD6B OTUD4	2.77e-03	17	84	2	669
GeneFamily	Beta 4-glycosyltransferases	B4GALT6 CHSY3	2.77e-03	17	84	2	425
GeneFamily	SRY-boxes	SOX4 SOX11	3.46e-03	19	84	2	757
GeneFamily	Phospholipases\|C2 domain containing phospholipases	PLCL2 PLCG1	3.46e-03	19	84	2	832
GeneFamily	Sialyltransferases	ST6GALNAC1 ST3GAL3	3.84e-03	20	84	2	438
GeneFamily	Endogenous ligands\|Matrix metallopeptidases	MMP28 MMP17	5.51e-03	24	84	2	891
GeneFamily	Acyl-CoA synthetase family	ACSL4 ACSBG1	6.45e-03	26	84	2	40
Coexpression	WENG_POR_DOSAGE	CYP2A6 CYP2A7 CYP2A13 CYP2B6	6.88e-06	30	108	4	MM1199
Coexpression	RHODES_CANCER_META_SIGNATURE	SOX4 OGT COPB2 CKS2 HDAC1	7.34e-06	65	108	5	M1345
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SOX11 STAB2 RHOJ WFS1 TMOD2 CHSY3 MMP17	5.03e-07	190	111	7	876bd2eb9ed2624cb23bdcf6b989e4fa34d099e3
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SOX11 STAB2 RHOJ WFS1 TMOD2 CHSY3 MMP17	5.03e-07	190	111	7	be9f36127028f52ca5fc1b32ba15a6c26aad69ac
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SOX11 STAB2 RHOJ WFS1 TMOD2 CHSY3 MMP17	5.03e-07	190	111	7	09a8855901c3c9332dbaab3e40166485b696d0f1
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ST6GALNAC1 CYP2A6 CYP2A7 CYP2A13 CYP2B6 NCKAP1	4.97e-06	174	111	6	42f2ba54b4ea4c62482582b0ccdadffae0a5eb4a
ToppCell	Control-Epithelial-Club\|Epithelial / Disease state, Lineage and Cell class	SOX4 ABCC3 CYP2A6 CYP2A7 CYP2A13 CYP2B6	7.05e-06	185	111	6	6814b3c94c7558443c038a227b5c8563d2cfeac4
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TENT5A ST3GAL3 CHN2 ITGAV IL1RAPL1 ACSL4	7.27e-06	186	111	6	de55471dd5c842026b409cfebf67fe32f079a011
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ST6GALNAC1 CYP2A6 CYP2A7 CYP2A13 CYP2B6 MSLN	8.98e-06	193	111	6	605fc2a25ed6846fb283b2918cfed98df6039d6b
ToppCell	3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TENT5A CHN2 IL1RAPL1 ACSL4 CKS2 BTK	8.98e-06	193	111	6	c17e87c042ef095ac99fdd6facf3bc2886924dc4
ToppCell	Goblet\|World / shred by cell class for turbinate	ST6GALNAC1 CYP2A6 CYP2A13 CYP2B6 ABCD1 MSLN	9.25e-06	194	111	6	03b62e7cff5e7a6e7bd7d9dda273c74bf9c1f42e
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SNX20 POTEF CKS2 SLC46A3 CD226 PCNA	9.80e-06	196	111	6	b71d711be5609115b00a57700885aca608920896
ToppCell	critical-Epithelial-Secretory\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ST6GALNAC1 SOX4 CYP2B6 NCKAP1 PER2 MSLN	9.80e-06	196	111	6	7da687eb983a54c28ee990424cc52e01caf5f4aa
ToppCell	distal-1-Epithelial-Club\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ST6GALNAC1 SOX4 CYP2A6 CYP2A7 CYP2A13 NIBAN2	1.07e-05	199	111	6	8f0a72a95d0310ef2324c6975495c294b5a47cc8
ToppCell	distal-3-Epithelial-Club\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ST6GALNAC1 SOX4 CYP2A6 TENT5A NIBAN2 MSLN	1.07e-05	199	111	6	1a0c3506df2438f5be40a8ea72effe5f8ebd35c4
ToppCell	distal-Epithelial-Club\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ST6GALNAC1 SOX4 CYP2A6 CYP2A7 NIBAN2 MSLN	1.07e-05	199	111	6	c63ccce1285352927fd8c4f7374ec5fff8d70cec
ToppCell	distal-Epithelial-Club-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ST6GALNAC1 SOX4 CYP2A6 CYP2A7 CYP2A13 NIBAN2	1.07e-05	199	111	6	685cefbe6ff5db8b578e50b5849524ac2f347d0c
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Mast_cell-Mast_cell\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	SOX4 IL1RAPL1 ACSL4 CKS2 BTK ZSWIM4	1.10e-05	200	111	6	a338b2b94901e4614ef78e82f580b67891f7c849
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Mast_cell\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	SOX4 IL1RAPL1 ACSL4 CKS2 BTK ZSWIM4	1.10e-05	200	111	6	21de2cf284c8d2aa464f3d403f0e292e1f654e0a
ToppCell	pdx-Tumor_cells-T9\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	SOX4 POLR2B TMOD2 ZNFX1 LATS2	3.06e-05	144	111	5	0b94d978262a826c9254145aa98c6c30240243f9
ToppCell	droplet-Lung-nan-3m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TENT5A LRRC58 CKS2 SLC46A3 PTPRJ	4.08e-05	153	111	5	6dcab3d50ab50051955204dc4e4a64c1ca855bcd
ToppCell	droplet-Lung-nan-3m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TENT5A LRRC58 CKS2 SLC46A3 PTPRJ	4.08e-05	153	111	5	f6ef14d949107c08cb3690e26ec91e194cb43518
ToppCell	droplet-Liver-Hepatocytes-18m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TENT5A MIER1 PTPRJ PLCL2 FAR1	4.48e-05	156	111	5	d72c2f5f72d269e29033f8728d924e0d4c8772c7
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122\|Adult / Lineage, Cell type, age group and donor	ST6GALNAC1 CYP2B6 MMP28 LRRK2 ST3GAL3	4.62e-05	157	111	5	31d1bd9138c60e8485664ec4144f987226e3eef9
ToppCell	droplet-Lung-3m-Hematologic-myeloid-non-classical_monocyte\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SNX20 TENT5A CKS2 SLC46A3 PTPRJ	5.52e-05	163	111	5	f6c8db5963ee1f8e0c2996f1aeecd58c00e9b099
ToppCell	droplet-Lung-3m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SNX20 TENT5A CKS2 SLC46A3 PTPRJ	5.68e-05	164	111	5	ea2897942ad72fba900c7ab354d6a9e203bf0e4a
ToppCell	Club_cells-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	ST6GALNAC1 SOX4 CYP2A6 CYP2A13 GLB1L3	6.19e-05	167	111	5	dbdaaeb3bd9139cb008d9fe24ec031fc5628f136
ToppCell	3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PLXNA3 ST3GAL3 ADAM32 ACSL4 ZSWIM4	6.37e-05	168	111	5	55f328353119cbdc521c782ebb8d163876f4186d
ToppCell	Control-Lymphoid-ILC_B\|Lymphoid / Disease state, Lineage and Cell class	SOX4 SOX11 RNF113B LATS2 GNAQ	6.37e-05	168	111	5	d7118d39253ed9790908b850088ebfc5a86f4065
ToppCell	facs-Lung-nan-3m-Endothelial-Vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAN2A1 MMP28 OTUD6B PRKD1 ZSWIM4	6.73e-05	170	111	5	8e1f757ed62218c0fb6525f49d142dd2cd29acf9
ToppCell	facs-Lung-nan-3m-Endothelial-vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAN2A1 MMP28 OTUD6B PRKD1 ZSWIM4	6.73e-05	170	111	5	67d7e1da3ebd2d14cb2e67799e94d655027ed5c4
ToppCell	3'-Distal_airway-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SNX20 AGPAT1 CHN2 SLC46A3 CD226	6.92e-05	171	111	5	1018d7bd378ce20bee56a77d5851b3538c55098c
ToppCell	cellseq2-Epithelial-Epithelial_Glandular-Goblet-Goblet\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ST6GALNAC1 CYP2A7 CYP2A13 CYP2B6 MSLN	6.92e-05	171	111	5	25c1979e972c959e1ce4c57804f976f53a247ad7
ToppCell	facs\|World / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NCKAP1 RHOJ ACSL4 PLCG1 GNAQ	6.92e-05	171	111	5	bb71e816dde44fda6af0ad98d979be9f8740fda6
ToppCell	cellseq2-Epithelial-Epithelial_Glandular-Goblet\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ST6GALNAC1 CYP2A7 CYP2A13 CYP2B6 MSLN	6.92e-05	171	111	5	fe27bf581c75ef33c2848878e51ed16b275a4c8e
ToppCell	facs-Lung-EPCAM-18m-Myeloid-Myeloid_Dendritic_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SNX20 TENT5A CHN2 B4GALT6 SLC46A3	6.92e-05	171	111	5	7c4362eeacbe52d7f4fdf93c841d7b59526328c1
ToppCell	3'-Distal_airway-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)-DC1_L.1.2.1.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SNX20 AGPAT1 CHN2 SLC46A3 CD226	6.92e-05	171	111	5	6bda333bb751d7835a04f21ac959eea79f2516aa
ToppCell	facs\|World / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NCKAP1 RHOJ ACSL4 PLCG1 GNAQ	6.92e-05	171	111	5	5bcb96ed7fc15548f2dc9cf47482f890640cb39c
ToppCell	3'-Distal_airway-Immune_Myeloid-Dendritic-conventional_dendritic_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SNX20 AGPAT1 CHN2 SLC46A3 CD226	6.92e-05	171	111	5	173bb5318fdbaef6e695b6f9e3e0ff4a5432a1a4
ToppCell	droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MMP28 LRRK2 SLC46A3 CD226 CHSY3	7.31e-05	173	111	5	70c0c13febd28b395fb3171ec8d7fbbc6c9d4eb7
ToppCell	E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	STAB2 SLC46A3 BTK MMP17 PLXNA1	7.31e-05	173	111	5	20f7dfe7d92a3dbec9da9a1f3185aa10cb8f0a3c
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	EXO5 B4GALT6 CHSY3 PLXNA1 ELP4	7.31e-05	173	111	5	7e2149205e119cec4f5099c83c85d1e13470137a
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CYP2A6 CYP2A7 CYP2B6 NIBAN2 CHSY3	8.37e-05	178	111	5	f5ed4a6e3eb8056b1be1fb311021710c95bdf888
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAN2A1 TMOD2 ITGAV IL1RAPL1 MSLN	8.59e-05	179	111	5	adf8b025032a03dbb58871a92025cd7efbeb22ff
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	CYP2A6 CYP2A7 CYP2B6 LRRK2 NIBAN2	9.05e-05	181	111	5	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	STAB2 RHOJ WFS1 CHSY3 MMP17	9.29e-05	182	111	5	41b070085edba7a58b81c20aa4942d06f745acf8
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	STAB2 RHOJ WFS1 CHSY3 MMP17	9.29e-05	182	111	5	5e9a67b2de0daa4fdc344b10a857d8a901ad810e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	STAB2 RHOJ WFS1 CHSY3 MMP17	9.29e-05	182	111	5	b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c
ToppCell	5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	STAB2 RHOJ WFS1 TMOD2 CHSY3	9.29e-05	182	111	5	53c267ee327e116dbd89d5927ed3bdf78d25ee62
ToppCell	PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_conventional_dendritic_(19)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SNX20 LRRK2 CHN2 SLC46A3 CD226	9.78e-05	184	111	5	315bb14e848d8e8e4533122047df6f9b89b89d99
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-mast_cell\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TENT5A CHN2 ITGAV IL1RAPL1 ACSL4	1.00e-04	185	111	5	3fafb1d36c5f98a29d20a5ce5192c83d6f603514
ToppCell	5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TENT5A CHN2 IL1RAPL1 ACSL4 BTK	1.03e-04	186	111	5	f690e26b2ed024bd8ede494b8e9a00976fdc9734
ToppCell	5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TENT5A CHN2 IL1RAPL1 ACSL4 BTK	1.05e-04	187	111	5	bdcef4f3e093c3646b639a189bbe93d6f4c40f3c
ToppCell	5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TENT5A CHN2 IL1RAPL1 ACSL4 BTK	1.05e-04	187	111	5	09348f1e8bbbca8dca885461937b9b1dd248b034
ToppCell	5'-Parenchyma_lung-Immune_Myeloid_mast\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TENT5A CHN2 IL1RAPL1 ACSL4 BTK	1.05e-04	187	111	5	0f7a42c55997e34a0d20e492e16b03e91e965335
ToppCell	5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TENT5A CHN2 IL1RAPL1 ACSL4 BTK	1.05e-04	187	111	5	064730fa72f8637c3db3fc34d2e363d2b9a38f1d
ToppCell	facs-Spleen-nan-3m-Lymphocytic-B_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1C LRRK2 LRRC58 PTPRJ BTK	1.05e-04	187	111	5	3ca3954f45f167e98a230f2847f0582d74fcd32e
ToppCell	Children_(3_yrs)-Epithelial-club_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ST6GALNAC1 CYP2A6 CYP2A7 CYP2B6 CHSY3	1.16e-04	191	111	5	23776c7302cead3881b39127398f3b3e0d27885e
ToppCell	IPF-Epithelial-Club\|World / Disease state, Lineage and Cell class	CYP2A6 CYP2A7 CYP2B6 NCKAP1 MSLN	1.16e-04	191	111	5	3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954
ToppCell	NS-critical-d_16-33-Epithelial-Secretory-diff\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ST6GALNAC1 CYP2A7 CYP2A13 CYP2B6 MSLN	1.19e-04	192	111	5	02b11233b4da2d85b96498b3c6e22e3a31b3d049
ToppCell	3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TENT5A CHN2 IL1RAPL1 ACSL4 BTK	1.19e-04	192	111	5	60a02e0ccdc8c7af9bc875b248467304fe0d24a4
ToppCell	3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TENT5A CHN2 IL1RAPL1 ACSL4 BTK	1.19e-04	192	111	5	b223fca73e16668f69a78cf4457e349d01792540
ToppCell	3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TENT5A CHN2 IL1RAPL1 ACSL4 BTK	1.19e-04	192	111	5	b5615a780b0ba24a8e554fac9238d3f0bcba52bc
ToppCell	3'-Parenchyma_lung-Immune_Myeloid_mast\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TENT5A CHN2 IL1RAPL1 ACSL4 BTK	1.19e-04	192	111	5	5532ea1bc012eb9303197b87e90bc39619b5ee2a
ToppCell	control-Lymphoid-CTL\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	OGT CHN2 PTPRJ CD226 PLCG1	1.22e-04	193	111	5	89d407a88b5956559a589425b89b3eb8dc78e1dd
ToppCell	myeloid-CD34+_Myeloblast\|World / Lineage and Cell class	SOX4 TENT5A B4GALT6 CKS2 PCNA	1.25e-04	194	111	5	426d5cf04e21fec2fb6ea51abd85441b2dc5c94f
ToppCell	droplet-Limb_Muscle-MUSCLE\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX11 LRRC58 MIER1 PER2 HECTD1	1.25e-04	194	111	5	e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SOX4 CYP2A6 TENT5A NIBAN2 MSLN	1.25e-04	194	111	5	db06ae2dba45640da329a4d0d94973ac9dda7729
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SOX4 CYP2A6 TENT5A NIBAN2 MSLN	1.25e-04	194	111	5	d3f5cd6c40354bfe86348bb0e82697a939759625
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-Secretory/RAS\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ST6GALNAC1 SOX4 CYP2A6 CYP2A7 CYP2B6	1.25e-04	194	111	5	0cd4363627acd419e00d6d32f6dce10430aa6487
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SOX4 CYP2A6 TENT5A NIBAN2 MSLN	1.25e-04	194	111	5	d4f4036b650a27312283fa8851f3975595cc2d3f
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-epithelial_cell_of_lung\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SOX4 CYP2A6 TENT5A NIBAN2 MSLN	1.25e-04	194	111	5	4974c208e6ee37a51cd95a61d48b26c5de416992
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-Secretory/RAS-RAS\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ST6GALNAC1 SOX4 CYP2A6 CYP2A7 CYP2B6	1.25e-04	194	111	5	a58841b34efe673671a9a059238e044a7254b279
ToppCell	10x5'v1-week_17-19-Endothelial-stroma-sinusoidal_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	STAB2 NCKAP1 RHOJ CHSY3 FBXO39	1.28e-04	195	111	5	22a481927147ec4ae9d59e6af7c87df0e9cb51e4
ToppCell	normal_Lung-Epithelial_cells-Club\|normal_Lung / Location, Cell class and cell subclass	ST6GALNAC1 SOX4 CYP2A6 CYP2A7 CYP2A13	1.28e-04	195	111	5	b46544ad5af04f4dbc2643637caa3d2d50d922ae
ToppCell	Epithelial_cells-Club_cells\|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id	ST6GALNAC1 SOX4 ABCC3 CYP2A6 CYP2A7	1.28e-04	195	111	5	b758676abfc4e6930b696d270ecc0ea461b87a54
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ST6GALNAC1 CYP2A6 CYP2A7 CYP2B6 CHSY3	1.28e-04	195	111	5	dccc32fcf772e2504de7f663ef0a5bd8e23e92fc
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Club\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ST6GALNAC1 SOX4 CYP2A6 CYP2A7 CYP2B6	1.28e-04	195	111	5	b9e8f405f6d837bb39b615836d3e2df349737c0e
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ST6GALNAC1 SOX4 CYP2A13 PER2 MSLN	1.28e-04	195	111	5	6095bb237d7bc75cbaeaeb492f6948f3c3fa4848
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-Club\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	ST6GALNAC1 CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.31e-04	196	111	5	4e4c632db73b1340d80bf40a7657cb4821084d3c
ToppCell	COPD-Epithelial-Club\|Epithelial / Disease state, Lineage and Cell class	SOX4 ABCC3 CYP2B6 MPRIP ZSWIM4	1.31e-04	196	111	5	af96fb94886e9395f3e2cd0a293af29229d017fe
ToppCell	AT1_cells-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	MYO1C WFS1 TGM1 PLXNA1 MSLN	1.35e-04	197	111	5	80d81be244c94c435accb643449b4ce6a3462c7f
ToppCell	3'_v3-GI_small-bowel-Mast-Mast_cells\|GI_small-bowel / Manually curated celltypes from each tissue	SOX4 TENT5A IL1RAPL1 ACSL4 BTK	1.38e-04	198	111	5	920d2e6603a06c2e8dcb6be127202d222c662bca
ToppCell	367C-Epithelial_cells-Epithelial-E_(AT2)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	LRRK2 NIBAN2 ACSL4 CKS2 MSLN	1.38e-04	198	111	5	85215015bb86ada0e871c413a4ecdc903a3785ca
ToppCell	distal-Epithelial-Club-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ST6GALNAC1 SOX4 CYP2A6 TENT5A MSLN	1.38e-04	198	111	5	e56a5ffadfa4d1e34d34aec43eaf560cd80286e1
ToppCell	normal_Lung-Epithelial_cells-Club\|Epithelial_cells / Location, Cell class and cell subclass	SOX4 ABCC3 CYP2A6 CYP2A7 CYP2A13	1.38e-04	198	111	5	a9d0109ca05eb3e9c588f9677ec471dd5c092a75
ToppCell	Biopsy_Control_(H.)-Epithelial-SCGB3A2+_SCGB1A1+\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	ST6GALNAC1 SOX4 CYP2A6 CYP2A7 CYP2A13	1.38e-04	198	111	5	a3d4b6e4259ded2193d94d2ff6d48cf67214fc35
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Club\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ST6GALNAC1 SOX4 CYP2A6 CYP2A13 CYP2B6	1.38e-04	198	111	5	5d57acbe0d245f8bd217eeea07af060092898fbd
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ST6GALNAC1 SOX4 CYP2A6 CYP2B6 CHSY3	1.38e-04	198	111	5	1408e02e053ad3406229bfe8189da03be6366e81
ToppCell	critical-Epithelial-FOXN4+\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	SOX4 USP13 CKS2 PCNA MSLN	1.38e-04	198	111	5	6b160b3d6a2c1b1641c2c7dcec1a7ef38411fec9
ToppCell	Biopsy_Other_PF-Immune-Mast_cells\|Biopsy_Other_PF / Sample group, Lineage and Cell type	CHN2 IL1RAPL1 ACSL4 NBAS BTK	1.38e-04	198	111	5	9f015553598d4c6774b2f9759e8c0f0f93e51c67
ToppCell	Biopsy_Control_(H.)-Epithelial-SCGB3A2+\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	ST6GALNAC1 SOX4 CYP2A6 CYP2B6 MSLN	1.38e-04	198	111	5	1fe51f4beca0eef4ff117e6edaa646e35c0f9629
ToppCell	3'_v3-GI_small-bowel-Mast\|GI_small-bowel / Manually curated celltypes from each tissue	SOX4 TENT5A IL1RAPL1 ACSL4 BTK	1.38e-04	198	111	5	807e3ed34739eca159dd0970f884b073e588c649
ToppCell	Epithelial_cells-AT1-AT2_cells\|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id	SOX4 ABCC3 MYO1C WFS1 PLXNA1	1.38e-04	198	111	5	fbc46b20bcd44f2083170aacbc6f5dd00fba685c
ToppCell	367C-Epithelial_cells-Epithelial-E_(AT2)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	LRRK2 NIBAN2 ACSL4 CKS2 MSLN	1.38e-04	198	111	5	38349e42a3f1fb700ff6dfd89c4bf5ff97f1a3e9
ToppCell	10x3'2.3-week_14-16-Endothelial\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	STAB2 NCKAP1 RHOJ WFS1 FBXO39	1.41e-04	199	111	5	41f046646fff65b7e51b63d3204f76ef32054781
ToppCell	proximal-Epithelial-Club\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SOX4 CYP2A6 TENT5A NIBAN2 MSLN	1.41e-04	199	111	5	99d23c0373f1ae5267bb3e51c5c88c8f52559ae4
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Transitional_AT2\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CYP2A6 CYP2A7 CYP2B6 NIBAN2 MSLN	1.41e-04	199	111	5	b44d74895846e2ac144438b73e0ca91e3949c16c
ToppCell	(7)_Epithelial_cells-(7)_Epithelial-I_(AT1)\|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	ABCC3 MYO1C WFS1 DDX60 PLXNA1	1.41e-04	199	111	5	5a002d49a8b84c158f7b4d7a3e78e6a937757bb7
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Transitional_AT2-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CYP2A6 CYP2A7 CYP2B6 NIBAN2 MSLN	1.41e-04	199	111	5	4b374a5de82b4614d3d8a00202ea6cb8f1fd8104
ToppCell	Biopsy_IPF-Epithelial-Transitional_AT2\|Biopsy_IPF / Sample group, Lineage and Cell type	MYO1C MMP28 LRRK2 NIBAN2 MSLN	1.41e-04	199	111	5	83ff8b7e472d1212324c05cc719b746d19e5e23b
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Club\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	ST6GALNAC1 CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.41e-04	199	111	5	2b17694cffbec28a2c8f165dfcff6bab94aa0f4c
Drug	2'-methoxyacetophenone	CYP2A6 CYP2A7 CYP2A13	1.13e-07	3	111	3	CID000068481
Drug	d 6-20	CYP2A6 CYP2A13 CYP2B6 ABCB5	3.70e-07	13	111	4	CID000161569
Drug	7-benzyloxyquinoline	CYP2A6 CYP2B6 CYP4A11 ABCB5	1.55e-06	18	111	4	CID003035604
Drug	D 703	CYP2A6 CYP2A13 CYP2B6 ABCB5	1.55e-06	18	111	4	CID000054088
Drug	debrisoquine	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11 LRRK2	1.79e-06	75	111	6	CID000002965
Drug	D 617	CYP2A6 CYP2A13 CYP2B6 ABCB5	1.96e-06	19	111	4	CID000093168
Drug	chloral hydrate	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11 CHN2 MSLN	3.31e-06	129	111	7	CID000002707
Drug	19-HETE	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	4.04e-06	49	111	5	CID006439528
Drug	14(15)-EpETrE	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11 GNAQ	4.90e-06	89	111	6	CID000001431
Drug	nicotine glucuronide	ABCC3 CYP2A6 ABCB5	6.20e-06	8	111	3	CID003035848
Drug	tienilic acid	ABCC3 CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	6.33e-06	93	111	6	CID000038409
Drug	BP-9,10-oxide	CYP2A6 CYP2A7 CYP2A13 CYP2B6	8.61e-06	27	111	4	CID000037456
Drug	Brn 4136738	CYP2A6 CYP2A7 CYP2A13 CYP2B6	8.61e-06	27	111	4	CID000050331
Drug	C14845	CYP2A6 CYP2A7 CYP2A13 CYP2B6	8.61e-06	27	111	4	CID011954064
Drug	AC1L1KIN	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11 ABCB5	9.63e-06	100	111	6	CID000005516
Drug	norverapamil	CYP2A6 CYP2A13 CYP2B6 ABCB5	1.00e-05	28	111	4	CID000104972
Drug	9-OH-BaP-4,5-oxide	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.00e-05	28	111	4	CID000115064
Drug	Menthol	ABCC3 CYP2A6 CYP2A13 CYP2B6	1.00e-05	28	111	4	ctd:D008610
Drug	5-OH-VPA	CYP2A6 CYP2B6 CYP4A11	1.32e-05	10	111	3	CID000135243
Drug	4-OH-VPA	CYP2A6 CYP2B6 CYP4A11	1.32e-05	10	111	3	CID000134466
Drug	19-hydroxytestosterone	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.33e-05	30	111	4	CID000150968
Drug	11-H-14,15-EETA	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.33e-05	30	111	4	CID011954058
Drug	chlorzoxazone	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	1.41e-05	63	111	5	CID000002733
Drug	BP-7,8-oxide	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.73e-05	32	111	4	CID000037455
Drug	D-702	CYP2A6 CYP2A13 CYP2B6	1.81e-05	11	111	3	CID000054077
Drug	piperonyl butoxide	ABCC3 CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.91e-05	67	111	5	CID000005794
Drug	propoxyphene	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	1.91e-05	67	111	5	CID000010100
Drug	rifampicin	ABCC3 CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11 ABCB5 POLR2B TGM1	1.94e-05	306	111	9	CID005381226
Drug	5,6-epoxyeicosatrienoic acid	CYP2A6 CYP2A7 CYP2A13 CYP2B6 GNAQ	2.05e-05	68	111	5	CID000001778
Drug	8(9)-EET	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	2.21e-05	69	111	5	CID000001901
Drug	12(13)-EpOME	CYP2A6 CYP2A7 CYP2A13 CYP2B6	2.22e-05	34	111	4	CID000001416
Drug	TCEO	CYP2A6 CYP2A7 CYP2A13 CYP2B6	2.22e-05	34	111	4	CID000028167
Drug	AC1O5XSP	CYP2A6 CYP2A7 CYP2A13 CYP2B6	2.22e-05	34	111	4	CID006442739
Drug	propargyl ether	CYP2A6 CYP2A13	2.36e-05	2	111	2	ctd:C531209
Drug	verbenone	CYP2A6 CYP2B6	2.36e-05	2	111	2	ctd:C052875
Drug	Hempa	CYP2A6 CYP2A13	2.36e-05	2	111	2	ctd:D006492
Drug	nicotine imine	CYP2A6 CYP2A13	2.36e-05	2	111	2	ctd:C034629
Drug	alpha-nicotyrine	CYP2A6 CYP2A13	2.36e-05	2	111	2	ctd:C008615
Drug	N-nitrosoguvacoline	CYP2A6 CYP2A13	2.36e-05	2	111	2	ctd:C036676
Drug	1h1q	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	2.37e-05	70	111	5	CID000001540
Drug	AC1L1CJI	CYP2A6 CYP2A7 CYP2A13 CYP2B6	2.49e-05	35	111	4	CID000001929
Drug	carteolol	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	2.71e-05	72	111	5	CID000002583
Drug	15-H-11,12-EETA	CYP2A6 CYP2A7 CYP2A13 CYP2B6	2.79e-05	36	111	4	CID011954042
Drug	AC1L3NGJ	CYP2A6 CYP2A7 CYP2A13 CYP2B6	2.79e-05	36	111	4	CID000092121
Drug	7-hydroxyquinoline	CYP2A6 CYP2B6 CYP4A11	3.11e-05	13	111	3	CID000011378
Drug	PhIP-HCl	ABCC3 CYP2A6 CYP2A13 CYP2B6 ABCB5 PCNA	3.13e-05	123	111	6	CID000001530
Drug	hexobarbital	CYP2A6 CYP2A7 CYP2A13 CYP2B6 NAA15 CYP4A11	3.75e-05	127	111	6	CID000003608
Drug	11,14,15-THET	CYP2A6 CYP2A7 CYP2A13 CYP2B6	3.86e-05	39	111	4	CID006439531
Drug	7-BFC	CYP2A6 CYP2B6 CYP4A11	3.95e-05	14	111	3	CID000848780
Drug	N-nitrosomethylaniline	CYP2A6 CYP2A7 CYP2A13	3.95e-05	14	111	3	CID000011957
Drug	trimipramine	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	4.52e-05	80	111	5	CID000005584
Drug	furafylline	KNTC1 CYP2A6 CYP2B6 CYP4A11	4.71e-05	41	111	4	CID000003433
Drug	AC1L7SPV	CYP2A6 CYP2B6 CYP4A11	4.92e-05	15	111	3	CID000366354
Drug	N'-nitrosonornicotine	CYP2A6 CYP2A13 PCNA	4.92e-05	15	111	3	ctd:C008655
Drug	Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A	SOX4 ABCC3 STAB2 PER2 PLCG1 MMP17 SOS2	5.19e-05	197	111	7	3886_DN
Drug	11,12,15-trihydroxyeicosatrienoic acid	CYP2A6 CYP2A7 CYP2A13 CYP2B6	5.19e-05	42	111	4	CID006439610
Drug	delavirdine	KNTC1 ABCC3 CYP2B6 ABCB5	5.19e-05	42	111	4	CID000005625
Drug	aminoglutethimide	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11 CD226	5.74e-05	137	111	6	CID000002145
Drug	diosmetin	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	6.05e-05	85	111	5	CID005281612
Drug	polybrominated biphenyl	CYP2A6 CYP2A7 CYP2A13 CYP2B6	6.25e-05	44	111	4	CID000042948
Drug	naphthalene-1,2-dihydrodiol	CYP2A6 CYP2A7 CYP2A13 CYP2B6	6.83e-05	45	111	4	CID000000362
Drug	5-hydroxyvalproate	CYP2A6 CYP2B6	7.04e-05	3	111	2	ctd:C091208
Drug	4-hydroxyvalproate	CYP2A6 CYP2B6	7.04e-05	3	111	2	ctd:C091207
Drug	2-propyl-4-pentenoic acid	CYP2A6 CYP2B6	7.04e-05	3	111	2	ctd:C045022
Drug	2-hydroxysebacate	ABCD1 MED12	7.04e-05	3	111	2	CID000128458
Drug	hexafluoron	CYP2A6 CYP2B6	7.04e-05	3	111	2	ctd:C058039
Drug	mephenytoin	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	7.14e-05	88	111	5	CID000004060
Drug	DMP 266	ABCC3 CYP2A6 CYP2B6 ABCB5	8.12e-05	47	111	4	CID000003203
Drug	C14802	CYP2A6 CYP2A7 CYP2A13 CYP2B6	8.12e-05	47	111	4	CID011954053
Drug	AC1L1R04	KNTC1 CYP2A6 CYP2B6 CYP4A11	8.12e-05	47	111	4	CID000008439
Drug	parathion	CYP2A6 CYP2A7 CYP2A13 CYP2B6 PCNA	8.38e-05	91	111	5	CID000000991
Drug	nitro-L	CYP2A6 CYP2A7 CYP2A13 CYP2B6	8.82e-05	48	111	4	CID000006849
Drug	C14800	CYP2A6 CYP2A7 CYP2A13 CYP2B6	8.82e-05	48	111	4	CID011954051
Drug	Ethylnitrosourea	NCKAP1 POMT1 CRYGB GNAQ HECTD1 MED12 PCNA HDAC1	9.15e-05	291	111	8	ctd:D005038
Drug	AC1L1BEQ	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	9.29e-05	93	111	5	CID000001407
Drug	lansoprazole	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	9.29e-05	93	111	5	CID000003883
Drug	bromobenzene-3,4-oxide	CYP2A6 CYP2A7 CYP2A13 CYP2B6	9.57e-05	49	111	4	CID000108121
Drug	Micotil	CYP2A6 CYP2B6 CYP4A11 TMOD2 LATS2 CD226	1.02e-04	152	111	6	CID000017675
Drug	bromobenzene-2,3-oxide	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.04e-04	50	111	4	CID003036760
Drug	xanthate	CYP2B6 RHOJ ACSBG1 PLCG1	1.04e-04	50	111	4	CID000008823
Drug	6-hydroxymelatonin	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.04e-04	50	111	4	CID000001864
Drug	1,1-dichloroethylene epoxide	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.04e-04	50	111	4	CID000119521
Drug	naphthalene epoxide	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.12e-04	51	111	4	CID000108063
Drug	mepivacaine	CYP2A6 CYP2A7 CYP2A13 PRKD1	1.12e-04	51	111	4	CID000004062
Drug	bromobenzene	ABCC3 CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.13e-04	97	111	5	CID000007961
Drug	propafenone	CYP2A6 CYP2A13 CYP2B6 CYP4A11 ABCB5	1.19e-04	98	111	5	CID000004932
Drug	PCB 77	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	1.19e-04	98	111	5	CID000036187
Drug	N-desmethyl-tamoxifen-hydrochloride	CYP2A6 CYP2B6 ABCB5 PRKD1	1.21e-04	52	111	4	CID000035887
Drug	olivacine	CYP2A6 CYP2B6 ABCB5	1.21e-04	20	111	3	CID005281407
Drug	9-hydroxybenzo(a)pyrene	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.30e-04	53	111	4	CID000028598
Drug	Sparteinum	CYP2A6 CYP2A7 CYP2A13 CYP2B6 CYP4A11	1.37e-04	101	111	5	CID000003966
Drug	dichloroacetaldehyde	CYP2A6 CYP2A7 CYP2A13 CYP2B6	1.40e-04	54	111	4	CID000006576
Drug	taxinine K	ABCB5 BTK	1.40e-04	4	111	2	CID005321708
Drug	5-hydroxycoumarin	CYP2A6 CYP2B6	1.40e-04	4	111	2	CID005318179
Drug	estragole	CYP2A6 PCNA	1.40e-04	4	111	2	ctd:C007633
Drug	N'-nitrosoanatabine	CYP2A6 CYP2A13	1.40e-04	4	111	2	ctd:C032978
Drug	chlorfluazuron	CYP2A6 CYP2B6	1.40e-04	4	111	2	ctd:C057223
Drug	NMPA	CYP2A6 CYP2A13	1.40e-04	4	111	2	CID000132101
Drug	carbon monoxide	CYP2A6 CYP2A7 CYP2A13 CYP2B6 RHOJ CYP4A11 PER2	1.48e-04	233	111	7	CID000000281
Drug	phenacetin	CYP2A6 CYP2A13 CYP2B6 CYP4A11	1.51e-04	55	111	4	CID000004754
Disease	nicotine metabolite ratio	CYP2A6 CYP2A7 CYP2B6	9.96e-06	12	107	3	EFO_0007794
Disease	Anorectal Malformations	SOX4 INTU MPRIP MED12	1.49e-05	41	107	4	C3495676
Disease	Cobblestone Lissencephaly	POMT1 TMTC3	3.90e-05	3	107	2	C0431376
Disease	caffeine metabolite measurement	CYP2A6 CYP2A7 CYP2B6	4.31e-05	19	107	3	EFO_0007872
Disease	Mental Retardation, X-Linked 1	IL1RAPL1 ACSL4 MED12	2.13e-04	32	107	3	C2931498
Disease	adrenoleukodystrophy (implicated_via_orthology)	ACSBG1 ABCD1	2.70e-04	7	107	2	DOID:10588 (implicated_via_orthology)
Disease	Malignant neoplasm of salivary gland	SOX4 SOX11 PRKD1	5.89e-04	45	107	3	C0220636
Disease	Salivary Gland Neoplasms	SOX4 SOX11 PRKD1	6.69e-04	47	107	3	C0036095
Disease	TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding)	CYP2A6 CYP2B6	8.40e-04	12	107	2	C1861063
Disease	Carcinoma, Granular Cell	CYP2A6 PRKD1 PCNA MSLN	8.57e-04	116	107	4	C0205644
Disease	Adenocarcinoma, Tubular	CYP2A6 PRKD1 PCNA MSLN	8.57e-04	116	107	4	C0205645
Disease	Adenocarcinoma, Oxyphilic	CYP2A6 PRKD1 PCNA MSLN	8.57e-04	116	107	4	C0205642
Disease	Carcinoma, Cribriform	CYP2A6 PRKD1 PCNA MSLN	8.57e-04	116	107	4	C0205643
Disease	Adenocarcinoma, Basal Cell	CYP2A6 PRKD1 PCNA MSLN	8.57e-04	116	107	4	C0205641
Disease	Adenocarcinoma	CYP2A6 PRKD1 PCNA MSLN	8.57e-04	116	107	4	C0001418
Disease	Coffin-Siris syndrome	SOX4 SOX11	9.90e-04	13	107	2	C0265338
Disease	Osteogenesis Imperfecta	TENT5A CRTAP	9.90e-04	13	107	2	C0029434
Disease	mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement	CEL CHN2 IL1RAPL1 CHSY3 GNAQ PTPN20	1.27e-03	328	107	6	EFO_0008377, EFO_0008378
Disease	response to platinum based chemotherapy, magnesium measurement	OTUD4 PRKD1	1.33e-03	15	107	2	EFO_0004647, EFO_0004845
Disease	pancreatic ductal carcinoma (is_marker_for)	MEN1 MSLN HDAC1	1.43e-03	61	107	3	DOID:3587 (is_marker_for)
Disease	HETE measurement	FAM91A1 NBAS CD226	1.50e-03	62	107	3	EFO_0801166
Disease	pancreatic ductal carcinoma (is_implicated_in)	MEN1 MSLN	1.51e-03	16	107	2	DOID:3587 (is_implicated_in)
Disease	breast carcinoma (is_marker_for)	SOX4 PLCG1 HDAC1	1.80e-03	66	107	3	DOID:3459 (is_marker_for)
Disease	Adrenocortical carcinoma	MEN1 MED12	1.92e-03	18	107	2	C0206686
Disease	Nonorganic psychosis	ST6GALNAC1 CYP2B6 MED12	2.04e-03	69	107	3	C0349204
Disease	colorectal cancer (is_marker_for)	LATS2 BTK PLCG1 HDAC1	2.60e-03	157	107	4	DOID:9256 (is_marker_for)
Disease	Osteogenesis imperfecta	TENT5A CRTAP	2.62e-03	21	107	2	cv:C0029434
Disease	Malignant tumor of colon	RHOJ ACTG2 PTPRJ PCNA	2.72e-03	159	107	4	C0007102
Disease	Colorectal Neoplasms	ABCC3 CYP2A6 ABCB5 CD226 PRKD1	3.43e-03	277	107	5	C0009404

Protein segments in the cluster

Peptide	Gene	Start	Entry
SKLMPYYLFHRSRGV	nan	71	Q6ZS49
LRNHYLKDIERMYGG	ACSL4	696	O60488
SPLILYYLKMHELAG	FAM227B	391	Q96M60
TLRYGFLLMLKYPHV	CYP2B6	306	P20813
FLLMLKYPHVAERVY	CYP2B6	311	P20813
RYGFLLLMKHPEVEA	CYP2A6	311	P11509
LYRPHLASEKVYTIM	BTK	616	Q06187
HLDRTMYLLGYIPKD	COPB2	556	P35606
HAELMAKRGLYYSLV	ABCB5	606	Q2M3G0
HYDILKPYVGLMADS	CYP4A11	151	Q02928
IYEGYALPHAIMRLD	ACTG2	166	P63267
LNLRPHDIAYLLIYM	ADAM32	266	Q8TC27
AIYYHIKNRDPDGRM	CCNY	126	Q8ND76
KVPLAGLEYPMLHYV	CEL	291	P19835
DATPMDAYLRKLGLY	OTUD4	21	Q01804
IRAMDTLKIPYKYEH	GNAQ	91	P50148
MAIYGYRHPLEEKDL	ABCC3	226	O15438
GEYMEKLSRLAYHPL	NIBAN2	386	Q96TA1
LLYDLGHLERYPMAL	MEN1	271	O00255
ARMFYHRPKYALLDE	ABCD1	616	P33897
GLDILSPMERFHLKY	EXO5	66	Q9H790
SPMERFHLKYLYVTD	EXO5	71	Q9H790
PDYLMKILTEHGYRF	POTEF	886	A5A3E0
DVYGIVYDLRMHRPL	PTPRJ	1266	Q12913
RLHSPMYYLLRGLSV	OR1B1	56	Q8NGR6
GLIYLDSRLHTPMYV	OR2A12	46	Q8NGT7
GMYDKILLFRHDPTS	PRKD1	96	Q15139
LYEHGLLRYALDEMP	MPRIP	76	Q6WCQ1
SHKAPAFLYDIYLRM	FAR1	356	Q8WVX9
FLGLMPYYKDHLERI	KCTD7	156	Q96MP8
YDGMEHLIYGEPRKL	MAGEA10	256	P43363
SLYLMLDRGHLDYPR	MAN2A1	21	Q16706
SLSIDRYHAIVYPMK	NPSR1	141	Q6W5P4
GLYRKMEIYRPHKAN	HDAC1	46	Q13547
LVLDPYLGFRTHKMN	KMT5C	21	Q86Y97
AALEYISKMGYLDPR	LATS2	131	Q9NRM7
TYMPYLHKALLRRGI	GLB1L3	236	Q8NCI6
ELLKYSRDHLMLYPY	FAM91A1	66	Q658Y4
QYMGHYLIRDERKDP	DDX60	741	Q8IY21
YHPFRMTPYLVKVRD	PER2	286	O15055
IADMGHLKYYLAPKI	PCNA	241	P12004
HRGSALPLAIKYMFD	PLXNA1	1706	Q9UIW2
HRGSALPLAIKYMFD	PLXNA3	1681	P51805
LEILPDMLEKHYGYK	IL1RAPL1	431	Q9NZN1
PMYYFLKHLSLLDLC	OR14J1	56	Q9UGF5
LGLMAYDRYVAISHP	OR2V2	116	Q96R30
GRYLEHLEVKFMNPY	FBXO39	86	Q8N4B4
GLRYLHSAMIIYRDL	LRRK2	1981	Q5S007
SGILHKLDPYDYEMI	KNTC1	1516	P50748
MAAFGILSYEHRPLK	MED12	1	Q93074
HLGYLFLKMSPEDIR	MSLN	371	Q13421
DRYLAIAKPLHYVTM	OR4D6	121	Q8NGJ1
MKYFDRLHPGDLITV	NBAS	1881	A2RRP1
RLLYMKEKPLTYEHG	RHOJ	146	Q9H4E5
SLPHRLSAAKMVYYL	NAA15	761	Q9BXJ9
VDFCGKYRLPLMHYL	LRRC58	316	Q96CX6
YMEELRAHVRKYGPV	NCKAP1	411	Q9Y2A7
FLLYPELMSRYGHRV	MEI1	786	Q5TIA1
EGRYFLLVVGLKHYM	INTU	586	Q9ULD6
DRYIAISKPLHYMTI	OR4D9	121	Q8NGE8
YIRYARKSHLTGPMV	PTPN20	336	Q4JDL3
LMEKTLFLYHYLPAL	POMT1	656	Q9Y6A1
EEYSKKPLILVYMRH	OTUD6B	256	Q8N6M0
KPLILVYMRHAYGLG	OTUD6B	261	Q8N6M0
VLMLLPPAHYETLRY	CHN2	391	P52757
HYLKLPEYSSEEIMR	HECTD1	2581	Q9ULT8
RYGFLLLMKHPEVEA	CYP2A13	311	Q16696
PRHFAAKLDKYMYIL	B4GALT6	246	Q9UBX8
RSDVRLYGMIYKPHA	DPP9	616	Q86TI2
RYGFLLLMKHPEVEA	CYP2A7	311	P20853
LMPLESAYRHALDKY	CRTAP	41	O75718
NTLLYILHYDIDGPM	ITGAV	836	P06756
IYELTVLKDPYTGMH	CELF5	71	Q8N6W0
LPYTVHRMFYEALDK	ACSBG1	101	Q96GR2
LIPPHSGAYRMKIYD	CRYGB	81	P07316
GHYYDASKRMPQELI	ELP4	181	Q96EB1
MDYPTLLLALLHVYR	CD226	1	Q15762
ILLGEYHAALPMLIY	SLC22A13	471	Q9Y226
EGDMPIHELLSLYGY	MIER1	61	Q8N108
MLYPLSHGFRKAIAE	OGT	511	O15294
ALMAPYYKRLGRDAL	MMP28	256	Q9H239
RLKHMADYPDYKYRP	SOX11	106	P35716
RLKHMADYPDYKYRP	SOX4	116	Q06945
KLIERLTYHMYADPN	SOS2	606	Q07890
LPLQELAMRGLYHTY	LRRC28	271	Q86X40
LGHDTVRALMYYALK	MMP17	151	Q9ULZ9
HSYLRYLKPKDTSMG	RNF113B	151	Q8IZP6
LRYLISYGKHTLDML	PLCL2	246	Q9UPR0
LLSISDHYGRKFPMI	SLC46A3	91	Q7Z3Q1
KAYFLGYMVHRLLLA	POLR2B	361	P30876
DRYLLLHPDFLRYMK	ST6GALNAC1	486	Q9NSC7
APLHYYETVRMAAIK	ST3GAL3	331	Q11203
YELEMYEKGLSARPH	MTG2	326	Q9H4K7
EEMYKLYPNARRAHL	SPG21	236	Q9NZD8
PMHGVEYILDLLLLY	CHSY3	531	Q70JA7
HYEYRHVMLPRELSK	CKS2	16	P33552
LARLHYIMGDYAEAL	CLUH	1026	O75153
RVYLGALKYMPHAVL	PRPF8	86	Q6P2Q9
EGHRYYAPLLDAMVR	SNX20	261	Q7Z614
RKAHGMLKLYYGLSE	VPS51	31	Q9UID3
YMELRGYPLRAFKLA	ZSWIM5	1006	Q9P217
LMLLHIKYLYGIRVE	AGPAT1	71	Q99943
LLDMLGYRNHYKVTA	TTC41P	626	Q6P2S7
DLISYYEKHPLYRKM	PLCG1	736	P19174
IPALIKYHMLLGTYR	STAB2	1056	Q8WWQ8
KYHMLLGTYRVADLQ	STAB2	1061	Q8WWQ8
SHVKEPRYLLMGGRY	ZNFX1	541	Q9P2E3
MREDITYLYKHPEGS	TGM1	536	P22735
NYLLSELKPMSYHLL	TMTC3	81	Q6ZXV5
AYLPSKRNHMLLLYP	WDR11	251	Q9BZH6
GLEDRKYEYLMTLHG	TENT5A	346	Q96IP4
TGPFDREHLLMYLEK	TMOD2	61	Q9NZR1
LEHYRDMGYPLAVKL	USP13	246	Q92995
YPLHAIMEIKEYLID	WFS1	291	O76024
YMEHRGLPLRAYKLA	ZSWIM4	811	Q9H7M6
VLVRHLGYKPEEYKM	MYO1C	696	O00159